Baylor University Medical Center at Dallas and Texas Oncology are celebrating more than 35 years of life-changing work in the field of inpatient blood and marrow transplantation. The inpatient program offered at Texas Oncology–Baylor Charles A. Sammons Cancer Center Blood and Marrow Transplant is one of the largest in the nation with a multidisciplinary team that focuses on everything from research to patient care. Over the past 35 years the program has performed 6,000 inpatient transplants, enrolled patients in numerous clinical trials, and expanded to a team of over 100 committed caregivers and support personnel.
A History of Quality
Complementing the inpatient services at Baylor University Medical Center, outpatient blood and marrow transplantation services are offered by Texas Oncology–Baylor Charles A. Sammons Cancer Center Blood and Marrow Transplant. The milestone 6,000th inpatient transplant would not have been possible without the involvement of physicians at Texas Oncology who evaluate patients and determine whether a transplant is the best treatment option.
“The advancements in medicine over the past 35 years have been nothing short of groundbreaking. We look forward to continuing this successful collaboration, focusing on offering patients the latest options available for treating leukemia, lymphoma, and all other blood cancers,” said Brian Berryman, M.D., medical oncologist and blood and marrow transplant specialist at Texas Oncology–Baylor Charles A. Sammons Cancer Center Blood and Marrow Transplant.
Continuing Innovation
Baylor Charles A. Sammons Cancer Center and Texas Oncology are committed to evolving blood and marrow transplantation services through research and groundbreaking therapies. These organizations are two of the first North Texas providers to offer chimeric antigen receptor T cell therapy (CAR-T) for patients with diffuse large B-cell lymphoma and acute lymphoblastic leukemia for patients under 25 years of age.
Baylor Scott & White Research Institute and Texas Oncology are enrolling more than two dozen clinical trials, including all phases, for patients diagnosed with cancers of the blood.
“To go from invasive surgeries and long recoveries to now offering outpatient procedures is a true transformation. I am honored to work alongside my esteemed colleagues at both Texas Oncology and Baylor Scott & White, two organizations focused on all aspects of medicine, from research to patient-driven care,” said Luis Piñeiro, M.D., medical director, blood and marrow transplant program at Baylor University Medical Center and medical oncologist and blood and marrow transplant specialist at Texas Oncology–Baylor Charles A. Sammons Cancer Center Blood and Marrow Transplant.